Spectrum of lymph node lesions as per recent Sydney system of lymph node classification

Verma S, Sinha R, Jaiswal CP

Pdf Page Numbers :- 280-284

Sonal Verma^1*, Reena Sinha¹ and Jaiswal CP¹

¹Department of Pathology, Nalanda Medical College, Patna, Bihar 800026, India

*Corresponding author: Dr. Sonal Verma, Assistant Professor, Department of Pathology, Nalanda Medical College, Patna, Bihar 800026, India. Email: drsonalvermanew@gmail.com

Received 23 June 2023; Revised 9 August 2023; Accepted 17 August 2023; Published 24 August 2023

Citation: Verma S, Sinha R, Jaiswal CP. Spectrum of lymph node lesions as per recent Sydney system of lymph node classification. J Med Sci Res. 2023; 11(4):280-284. DOI: http://dx.doi.org/10.17727/JMSR.2023/11-52

Copyright: © 2023 Verma S et al. Published by KIMS Foundation and Research Center. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

PDF

Abstract

Background: Lymphadenopathy may be an incidental finding and/or primary or secondary manifestation of underlying diseases which may be neoplastic or non-neoplastic. The aim of the current study was to evaluate the spectrum of lymph node lesions according to the Sydney system in our setting and to assess the risk of malignancy in each category.

Methods: The present study was carried out in the Department of Pathology, Nalanda Medical College and Hospital, Patna (Bihar) retrospectively during a one-year period from November 2020 to October 2021. 332 FNACs were performed on patients and the ROM (Risk of Malignancy) was assessed for each diagnostic category.

Results: In the present study, 11 cases were categorized as L1, inadequate/non-diagnostic; 291 cases as L2,benign; 06 cases as L3, AUS/ALUS; 03 as L4, Suspicious for malignancy, and finally 21 cases were categorized as L5, Malignant. The ROM was 1.28% in L2, 50% in L3, and 100% in L4,L5. ROM for L1 category could not be assessed.

Conclusion: The universal implementation of the Sydney system of reporting lymph node cytopathology can improve the diagnostic accuracy which will not only instill confidence in the pathologists but also help the clinicians to adopt better management strategies.

Keywords: granulomatous; lymphadenitis; lymphoma; metastases; malignancy